Blog
GrafTech Announces Fourth Quarter 2022 Cash Dividend
The Board of Directors of GrafTech International Ltd. (NYSE:EAF) (the “Company”) declared a quarterly cash dividend of $0.01 per share to stockholders of record as of the close of business on
Archaea Energy Inc. Reports Results for the Three and Nine Months Ended September 30, 2022
Archaea Energy Inc. (“Archaea,” “the Company,” or “we”) (NYSE: LFG), one of the largest producers of renewable natural gas (“RNG”) in the U.S., today announced financial and operating results for
Vistagen Reports Second Quarter Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system
US Foods to Present at the 2022 Barclays Eat, Sleep, Play Conference
US Foods Holding Corp. (NYSE: USFD) announced today that Dirk Locascio, chief financial officer, will participate in a fireside chat at the Barclays Eat, Sleep, Play Conference in New York City on
Stevanato Group to Present at Upcoming Investor Conference
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries
COPT Declares 100th Consecutive Common Dividend
Corporate Office Properties Trust (NYSE: OFC) (“COPT” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.275 per common share for the fourth
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2022 and provided
Xylem Inc. Declares Fourth Quarter Dividend of 30 Cents per Share
The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a fourth quarter dividend of $0.30 per share payable on December 20, 2022 to shareholders of record as of November 22, 2022.
About
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and
Eaton achieves Mansfield Rule certification: What this means for the future of inclusion and diversity
Intelligent power management company Eaton (NYSE:ETN) is excited to announce that it has been named a Mansfield 2.0 Certified Legal Department (MRLD) and achieved the MRLD Certification Plus
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that
IMV Inc. Announces Third Quarter 2022 Financial and Operational Results
IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat
Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended
Columbia Care Continues Footprint Expansion in Virginia with New Dispensary Opening in Richmond
Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter
Redfin Reports Annual Home Price Growth Slows to 3%
(NASDAQ: RDFN) — Home-sale prices rose 3.2% year over year during the four-week period ending November 6, the smallest increase since July 2020, according to a new report from Redfin (redfin.com)
Emma de Sousa to step down as Insight’s EMEA President; Adrian Gregory to take the helm
Insight Enterprises (NASDAQ:NSIT), a Fortune 500 solutions integrator helping organizations accelerate their digital journey, announced today that Emma de Sousa is stepping down from her current
Teleperformance: Resuming Trading of Shares
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, has requested Euronext Paris to resume the
ServiceNow to Present at Upcoming Investor Conferences
ServiceNow (NYSE: NOW) today announced that it will attend and have executives present at three upcoming investor conferences. These include:
-
ServiceNow Chairman and Chief Executive Officer Bill
Employee Engagement is Key in the New Talent Landscape
Enterprises and service providers are facing a talent crunch that requires them to double down on employee engagement programs to attract and retain people with critical skill sets, says an expert
U.S. News and World Report names Humana 2023 Best Overall Medicare Advantage Plan Company
Humana recently received recognition as U.S. News & World Report’s Best Insurance Company for Medicare Advantage in three categories for 2023.
This press release features multimedia. View the full
T-Mobile Expands 5G Home Internet to Millions Across the Midwest
T-Mobile is taking over the Midwest, folks! Today, T-Mobile (NASDAQ: TMUS) announced it has expanded the footprint of its 5G Home Internet service across Illinois, Michigan and Wisconsin, where
UBS Advisor Jonathan Beukelman Named to the Forbes/SHOOK Top 250 Wealth Advisors List
UBS Private Wealth Management announced today that Jonathan Beukelman, a Managing Director and Private Wealth Advisor in Denver, Colorado, has been named to the Forbes/SHOOK Research Top 250 Wealth
Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the
FSD Pharma Announces Arbitrator Dismisses Claims by Former CEO, Dr. Raza Bokhari
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to


